Free Trial

Life Science REIT (LABS) Competitors

Life Science REIT logo
GBX 39.89 +0.29 (+0.72%)
As of 08/1/2025 12:10 PM Eastern

LABS vs. IHR, MXF, AGR, PHP, THRL, MLI, WHR, RDI, PCTN, and MTVW

Should you be buying Life Science REIT stock or one of its competitors? The main competitors of Life Science REIT include Impact Healthcare REIT (IHR), Medicx Fund (MXF), Assura (AGR), Primary Health Properties (PHP), Target Healthcare REIT (THRL), Industrials REIT (MLI), Warehouse REIT (WHR), Rdi Reit (RDI), Picton Property Income (PCTN), and Mountview Estates (MTVW). These companies are all part of the "real estate" sector.

Life Science REIT vs. Its Competitors

Life Science REIT (LON:LABS) and Impact Healthcare REIT (LON:IHR) are both small-cap real estate companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability.

67.3% of Life Science REIT shares are owned by institutional investors. Comparatively, 59.5% of Impact Healthcare REIT shares are owned by institutional investors. 7.0% of Life Science REIT shares are owned by insiders. Comparatively, 9.3% of Impact Healthcare REIT shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Life Science REIT has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500. Comparatively, Impact Healthcare REIT has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500.

Life Science REIT presently has a consensus target price of GBX 46.50, indicating a potential upside of 16.58%. Given Life Science REIT's stronger consensus rating and higher probable upside, analysts clearly believe Life Science REIT is more favorable than Impact Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Life Science REIT
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Impact Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Impact Healthcare REIT has a net margin of 88.90% compared to Life Science REIT's net margin of -198.99%. Impact Healthcare REIT's return on equity of 9.90% beat Life Science REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Life Science REIT-198.99% -14.53% 1.25%
Impact Healthcare REIT 88.90%9.90%4.30%

In the previous week, Life Science REIT and Life Science REIT both had 1 articles in the media. Impact Healthcare REIT's average media sentiment score of 1.00 beat Life Science REIT's score of 0.59 indicating that Impact Healthcare REIT is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Life Science REIT
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Impact Healthcare REIT
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Life Science REIT pays an annual dividend of GBX 2 per share and has a dividend yield of 5.0%. Impact Healthcare REIT pays an annual dividend of GBX 7 per share. Life Science REIT pays out -17.7% of its earnings in the form of a dividend. Impact Healthcare REIT pays out 6,363.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Life Science REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

Impact Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Impact Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Life Science REIT£20.41M6.94-£40.62M-£11.28-3.54
Impact Healthcare REIT£53.51M0.00£47.58M£0.11N/A

Summary

Impact Healthcare REIT beats Life Science REIT on 10 of the 16 factors compared between the two stocks.

Get Life Science REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

MetricLife Science REITREIT IndustryReal Estate SectorLON Exchange
Market Cap£141.61M£1.61B£1.59B£3.03B
Dividend Yield5.67%7.52%6.26%5.02%
P/E Ratio-3.541.3610.63176.75
Price / Sales6.94526.721,066.05264,362.45
Price / CashN/A49.2266.7927.97
Price / Book0.521.391.324.53
Net Income-£40.62M-£74.43M-£120.13M£5.90B
7 Day Performance-8.52%-1.44%-0.74%12.58%
1 Month Performance-9.76%-2.52%-0.64%4.67%
1 Year Performance17.31%13.83%9.05%72.88%

Life Science REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
Life Science REIT
1.7978 of 5 stars
GBX 39.89
+0.7%
GBX 46.50
+16.6%
+17.3%£141.61M£20.41M-3.54N/A
IHR
Impact Healthcare REIT
N/AN/AN/AN/A£361.75M£53.51M793.64N/ANews Coverage
Positive News
MXF
Medicx Fund
N/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading Volume
AGR
Assura
1.4998 of 5 stars
GBX 49.92
+0.1%
GBX 51
+2.2%
+18.0%£1.63B£188.76M-47.7284
PHP
Primary Health Properties
2.7742 of 5 stars
GBX 96.50
+0.4%
GBX 107.50
+11.4%
+3.2%£1.30B£178.59M-150.6358Trending News
Insider Trade
THRL
Target Healthcare REIT
N/AGBX 97.70
-1.8%
N/A+21.4%£598.03M£68.64M8.19N/A
MLI
Industrials REIT
N/AN/AN/AN/A£494.79M£50.19M1,050.005,140News Coverage
WHR
Warehouse REIT
N/AGBX 114.60
+0.4%
N/A+32.8%£485.47M£50.81M1.1161,000
RDI
Rdi Reit
N/AN/AN/AN/A£462.34M£68.40M-4.442,020
PCTN
Picton Property Income
N/AGBX 77.30
-1.5%
N/A+1.8%£418.61M£54.17M51.8810
MTVW
Mountview Estates
N/AGBX 9,691
-1.1%
N/A+4.8%£369.57M£77.73M21.2429News Coverage
Positive News
Dividend Cut

Related Companies and Tools


This page (LON:LABS) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners